Skip to Content

L49 (Darifenacin Hydrobromide Extended-Release 15 mg)

Pill with imprint L49 is Peach, Round and has been identified as Darifenacin Hydrobromide Extended-Release 15 mg. It is supplied by Macleods Pharmaceuticals Limited.

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L49

Darifenacin Hydrobromide Extended-Release

Imprint
L49
Strength
15 mg
Color
Peach
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
Manufacturer
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0277
Inactive Ingredients
calcium phosphate dibasic anhydrous, silicon dioxide, magnesium stearate, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow, hypromelloses, polyethylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L49"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.